Undervalued Stocks Based On Cash Flows

Results

716

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

716 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
BBT
US$30.22-2.2%14.9%US$2.5bUS$33.171.042.5%4.3%Banks
688617
CN¥194.481.8%-32.5%CN¥27.4bCN¥335.3931.723.0%0.5%Healthcare
ARML3
R$2.95-2.0%-22.4%R$1.0bR$5.9620.254.2%20.9%Capital Goods
605056
CN¥16.023.8%2.6%CN¥6.6bn/a24.831.1%2.4%Capital Goods
RYN
US$21.49-0.8%-5.2%US$6.5bUS$26.001.243.2%11.4%Real Estate
GGPS3
R$12.396.0%-16.2%R$9.3bR$20.9314.125.8%2.6%Commercial Services
LOV
AU$22.49-5.8%-26.5%AU$2.5bAU$28.9328.415.5%3.4%Retail
AMRQ.F
US$1.115.9%3.0%US$518.2mn/a16.0127.3%n/aMaterials
HAG
€80.1818.7%-20.8%€8.7b€90.3092.631.7%0.7%Capital Goods
KVYO
US$16.9013.2%-50.1%US$5.1bUS$28.823.982.4%n/aSoftware
ENT
UK£5.32-10.1%-41.6%UK£3.4bUK£9.470.689.4%3.7%Consumer Services
GROY
US$2.864.0%20.2%US$727.7mUS$6.0037.0116.4%0%Materials
A039840
₩12,840.000.3%-29.5%₩172.3b₩22,666.6721.137.8%n/aHealthcare
NTRA
US$279.322.6%76.0%US$40.0bUS$264.5716.058.1%n/aPharmaceuticals & Biotech
ESQ
US$120.341.3%20.9%US$985.9mUS$125.003.351.0%0.7%Banks
JMT
€16.34-6.1%-29.1%€10.4b€23.7516.113.2%4.0%Consumer Retailing
HIAB
€53.90-1.5%3.9%€3.5b€66.6025.825.2%2.2%Capital Goods
JST
€55.409.3%3.2%€911.3m€75.0079.644.0%2.7%Capital Goods
SEYE
SEK 88.101.2%19.9%SEK 3.4bSEK 114.007.786.1%n/aTech
PCOR
US$43.977.2%-38.5%US$6.6bUS$69.004.8115.1%n/aSoftware
JAN
US$29.121.1%n/aUS$8.4bUS$30.182.9116.6%2.0%Real Estate
1318
HK$55.953.6%-47.7%HK$27.4bHK$104.0919.717.2%2.1%Household
DYVOX
SEK 65.707.8%-42.0%SEK 7.0bSEK 110.2039.131.2%0.8%Tech
A089030
₩46,100.00-10.7%52.1%₩1.6t₩80,000.00360.1100.0%0.3%Semiconductors
Page 1 of 20